Project: Company Due Diligence • The problem: A German Biotech company ran into financial problems, primary clinical data of the most advanced product ... Project: Company Due Diligence - ACCELLA ADVISORS GmbH | 26.05.2016 00:28:14 http://accella-advisors.com/reference4.html

Project: Business Development • The problem: A German biotech company wanted to enhance its pipeline through in-licensing of products with strategic fit ... Project: Business Development - ACCELLA ADVISORS GmbH ... 26.05.2016 00:28:14 http://accella-advisors.com/reference2.html

Project: Financing • The problem: A German biotech company needed support in their fundraising for a first institutional round. • The solution Project: Financing - ACCELLA ADVISORS GmbH 26.05.2016 00:28:14 http://accella-advisors.com/reference1.html

Project: Market Entry Study • The problem: A Japanese pharmaceutical company wanted to evaluate the market opportunity for a cardiovascular product in ... Project: Market Entry Study - ACCELLA ADVISORS GmbH ... 26.05.2016 00:28:13 http://accella-advisors.com/reference3.html

Services for Investors. Most venture funds have a company portfolio with a wide range of technologies. Considering the fast development of new technologies ... ACCELLA ADVISORS GmbH: Services for Investors 26.05.2016 00:28:13 http://accella-advisors.com/service2.html

Services for Non- European Pharma and Biotech Companies. Midsize pharma and biotech companies (US, Japan, India) often lack market knowledge for growing ... ACCELLA ADVISORS GmbH: Services for Non- European Pharma ... 26.05.2016 00:28:13 http://accella-advisors.com/service3.html

Project: Turnaround Management • The problem: An Austrian biotech company with an innovative mechanism of action had problems rounding out the syndicate ... Project: Turnaround Management - ACCELLA ADVISORS GmbH ... 26.05.2016 00:28:13 http://accella-advisors.com/reference5.html